MannKind appoints new EVP as executive plans retirement

MNKD Stock  USD 5.65  0.01  0.18%   
About 67% of MannKind Corp's investor base is looking to short. The analysis of the overall investor sentiment regarding MannKind Corp suggests that many traders are alarmed. The current market sentiment, together with MannKind Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use MannKind Corp stock news signals to limit their universe of possible portfolio assets.
  
MannKind appoints new EVP as executive plans retirement

Read at investing.com
Investing News at Macroaxis
  

MannKind Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards MannKind Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

MannKind Corp Fundamental Analysis

We analyze MannKind Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MannKind Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MannKind Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

MannKind Corp is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

MannKind Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MannKind Corp stock to make a market-neutral strategy. Peer analysis of MannKind Corp could also be used in its relative valuation, which is a method of valuing MannKind Corp by comparing valuation metrics with similar companies.

Peers

MannKind Corp Related Equities

NRXPWNRx Pharmaceuticals   31.25   
0%
100.0%
ELEVElevation Oncology   4.69   
0%
15.0%
ADAPAdaptimmune Therapeutics   3.39   
0%
10.0%
KNSAKiniksa Pharmaceuticals   3.36   
0%
10.0%
IMMPImmutep   3.05   
0%
9.0%
AFMDAffimed NV   2.94   
0%
9.0%
DAWNDay One   2.37   
0%
7.0%
VSTMVerastem   2.35   
0%
7.0%
INKTMink Therapeutics   2.30   
0%
7.0%
LQDALiquidia Technologies   1.40   
0%
4.0%
SGMOSangamo Therapeutics   0.79   
0%
2.0%
BMRNBiomarin Pharmaceutical   0.23   
0%
1.0%
UTHRUnited Therapeutics   0.12   
1.0%
0%
TECHBio Techne   0.32   
1.0%
0%
PCVXVaxcyte   0.36   
1.0%
0%
SABSSAB Biotherapeutics   2.75   
8.0%
0%
LEGNLegend Biotech   4.40   
14.0%
0%
LRMRLarimar Therapeutics   6.02   
19.0%
0%
KTTAPasithea Therapeutics   21.90   
70.0%
0%

Complementary Tools for MannKind Stock analysis

When running MannKind Corp's price analysis, check to measure MannKind Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MannKind Corp is operating at the current time. Most of MannKind Corp's value examination focuses on studying past and present price action to predict the probability of MannKind Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MannKind Corp's price. Additionally, you may evaluate how the addition of MannKind Corp to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation